Abivax SA ADR (ABVX)

Currency in USD
9.95
-0.39(-3.77%)
Closed·
After Hours
10.06+0.11(+1.11%)
·
ABVX Scorecard
Full Analysis
Quickly burning through cash
ABVX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.8610.32
52 wk Range
4.7713.17
Key Statistics
Prev. Close
10.34
Open
10.32
Day's Range
9.86-10.32
52 wk Range
4.77-13.17
Volume
589.42K
Average Volume (3m)
305.84K
1-Year Change
-22.14%
Book Value / Share
-0.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABVX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
36.63
Upside
+268.09%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Abivax SA ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Abivax SA ADR Company Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn’s disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Compare ABVX to Peers and Sector

Metrics to compare
ABVX
Peers
Sector
Relationship
P/E Ratio
−2.9x−2.5x−0.5x
PEG Ratio
−0.270.030.00
Price/Book
−83.0x1.3x2.6x
Price / LTM Sales
51.7x4.8x3.2x
Upside (Analyst Target)
311.0%171.1%43.8%
Fair Value Upside
Unlock6.8%5.1%Unlock

Analyst Ratings

7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 36.63
(+268.09% Upside)

Earnings

Latest Release
Jun 02, 2025
EPS / Forecast
-0.9741 / -0.68
Revenue / Forecast
1.17M / --
EPS Revisions
Last 90 days

ABVX Income Statement

People Also Watch

7.95
PHAT
-4.45%
27.50
YB
+3.97%
40.39
AAPG
+2.88%
3.3500
ABVC
-6.42%
38.10
EXOD
+4.96%

FAQ

What Is the Abivax ADR (ABVX) Stock Price Today?

The Abivax ADR stock price today is 9.95

What Stock Exchange Does Abivax ADR Trade On?

Abivax ADR is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Abivax ADR?

The stock symbol for Abivax ADR is "ABVX."

What Is the Abivax ADR Market Cap?

As of today, Abivax ADR market cap is 641.20M.

What Is Abivax ADR's Earnings Per Share (TTM)?

The Abivax ADR EPS (TTM) is -2.94.

When Is the Next Abivax ADR Earnings Date?

Abivax ADR will release its next earnings report on 10 Aug 2025.

From a Technical Analysis Perspective, Is ABVX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Abivax ADR Stock Split?

Abivax ADR has split 0 times.

How Many Employees Does Abivax ADR Have?

Abivax ADR has 69 employees.

What is the current trading status of Abivax ADR (ABVX)?

As of 18 July 2025, Abivax ADR (ABVX) is trading at a price of 9.95, with a previous close of 10.34. The stock has fluctuated within a day range of 9.86 to 10.32, while its 52-week range spans from 4.77 to 13.17.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.